Boehringer Ingelheim Partners with Rectify to Develop Oral Medications for Chronic Kidney Disease
Boehringer Ingelheim has entered into a strategic partnership with Boston-based startup Rectify to develop oral…
Newswire
AstraZeneca Invests $100 Million Upfront in Jacobio’s Pan-KRAS Inhibitor
AstraZeneca is committing $100 million upfront to acquire ex-China rights for Jacobio Pharma’s early-stage cancer…
CMMI Proposes New Models to Lower Drug Prices to International Rates for Medicare Parts B, D
The Centers for Medicare & Medicaid Services’ (CMS) Innovation Center has unveiled two new drug…
Trump Administration Secures Pricing Deals with Nine Additional Pharma Companies
The Trump administration has successfully negotiated pricing agreements with nine more pharmaceutical companies, leaving only…
Boehringer’s Jascayd Quickly Expands Lung Disease Reach with New FDA Nod
Boehringer Ingelheim’s Jascayd has received FDA approval to target progressive pulmonary fibrosis, marking a significant…
FDA Grants Early Approval for Cytokinetics’ Myqorzo, Marking a Milestone for the Biotech
The FDA has granted early approval for Cytokinetics’ aficamten, a significant milestone for the biotech…
MHRA Emphasizes Simple Health Choices for Winter Wellness Amid Rising Cold Cases
As the cold weather approaches, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has…
NIH Study on Topical Steroid Withdrawal Faces Setbacks Amid Federal Changes
On May 23, 2023, Kelly Barta arrived at the National Institutes of Health to address…
Federal Cuts Threaten U.S. Food Safety Amid Rising Health Risks
The recent infant botulism outbreak linked to ByHeart formula, which affected dozens of infants, underscores…
Novartis and US Government Finalize Agreement to Lower Drug Prices
Novartis has finalized an agreement with the US government aimed at reducing the prices of…